相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Virtual screening and in vitro experiments highlight cannabidiol as a drug-like phosphodiesterase 9 inhibitor
Giovanni Ribaudo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2023)
The Safety and Efficacy of Psychedelic-Assisted Therapies for Older Adults: Knowns and Unknowns
C. Bree Johnston et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2023)
Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome
Antonio Inserra et al.
BRITISH JOURNAL OF PHARMACOLOGY (2023)
Mescaline: The forgotten psychedelic*
Ioanna A. Vamvakopoulou et al.
NEUROPHARMACOLOGY (2023)
The substrate import mechanism of the human serotonin transporter
Matthew C. Chan et al.
BIOPHYSICAL JOURNAL (2022)
Diversity, biology, and history of psilocybin-containing fungi: Suggestions for research and technological development
R. C. Van Court et al.
FUNGAL BIOLOGY (2022)
N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine
Edward James et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2022)
Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up
Natalie Gukasyan et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2022)
Why was early therapeutic research on psychedelic drugs abandoned?
Wayne Hall
PSYCHOLOGICAL MEDICINE (2022)
Structure-based discovery of nonhallucinogenic psychedelic analogs
Dongmei Cao et al.
SCIENCE (2022)
Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder
Athanasios Markopoulos et al.
FRONTIERS IN PHARMACOLOGY (2022)
Receptor Interaction Profiles of 4-Alkoxy-3,5-Dimethoxy-Phenethylamines (Mescaline Derivatives) and Related Amphetamines
Karolina E. Kolaczynska et al.
FRONTIERS IN PHARMACOLOGY (2022)
The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects
Malin Vedoy Uthaug et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2022)
Communalistic use of psychoactive plants as a bridge between traditional healing practices and Western medicine: A new path for the Global Mental Health movement
Genis Ona et al.
TRANSCULTURAL PSYCHIATRY (2022)
Genetic Survey of Psilocybe Natural Products
Sebastian Doerner et al.
CHEMBIOCHEM (2022)
Teacher plants - Indigenous Peruvian-Amazonian dietary practices as a method for using psychoactives
Ilana Berlowitz et al.
JOURNAL OF ETHNOPHARMACOLOGY (2022)
Safety, tolerability, pharmacokinetics, and subjective effects of 50, 75, and 100 μg LSD in healthy participants within a novel intervention paradigm: A proof-of-concept study
Neiloufar Family et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2022)
Increased global integration in the brain after psilocybin therapy for depression
Richard E. Daws et al.
NATURE MEDICINE (2022)
Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder
Deepak Cyril D'Souza et al.
NEUROPSYCHOPHARMACOLOGY (2022)
Role of 5-HT2A receptors in the effects of ayahuasca on ethanol self-administration using a two-bottle choice paradigm in male mice
Yasmim A. Serra et al.
PSYCHOPHARMACOLOGY (2022)
Structure-Activity Relationships of Dopamine Transporter Pharmacological Chaperones
Charles Sutton et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2022)
Effect of Psilocybin and Ketamine on Brain Neurotransmitters, Glutamate Receptors, DNA and Rat Behavior
Adam Wojtas et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Different Seasonal Collections of Ficus carica L. Leaves Diversely Modulate Lipid Metabolism and Adipogenesis in 3T3-L1 Adipocytes
Mariachiara Pucci et al.
NUTRIENTS (2022)
Molecular insights into the regulation of constitutive activity by RNA editing of 5HT2C serotonin receptors
Ryan H. Gumpper et al.
CELL REPORTS (2022)
Psychedelic-Assisted Psychotherapy-A Systematic Review of Associated Psychological Interventions
Mauro Cavarra et al.
FRONTIERS IN PSYCHOLOGY (2022)
Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice
Grant C. Glatfelter et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2022)
Modalities of the psychedelic experience: Microclimates of set and setting in hallucinogen research and culture
Ido Hartogsohn
TRANSCULTURAL PSYCHIATRY (2022)
Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response
I Erkizia-Santamaria et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Development and validation of an LC-MS/MS method for the quantification of mescaline and major metabolites in human plasma
Jan Thomann et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2022)
Signaling snapshots of a serotonin receptor activated by the prototypical psychedelic LSD
Can Cao et al.
NEURON (2022)
Psychedelic-assisted psychotherapy to treat psychiatric and existential distress in life-threatening medical illnesses and palliative care
S. Ross et al.
NEUROPHARMACOLOGY (2022)
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression
Guy M. Goodwin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Knowing and being known: Psychedelic-assisted psychotherapy and the sense of authenticity
Lawrence G. G. Fischman
FRONTIERS IN PSYCHIATRY (2022)
Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant
Giordano Novak Rossi et al.
BIOMOLECULES (2022)
Potential and Limits of Cannabinoids in Alzheimer's Disease Therapy
Giulia Abate et al.
BIOLOGY-BASEL (2021)
Is distyly in subtropical Psychotria brachyceras (Rubiaceae) similar to the general trends observed for the genus?
Renata Trevizan et al.
ACTA BOTANICA BRASILICA (2021)
Synergistic effects of lysergic acid diethylamide (LSD) and cannabidiol (CBD)
A. Inserra et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2021)
A non-hallucinogenic psychedelic analogue with therapeutic potential
Lindsay P. Cameron et al.
NATURE (2021)
Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission
Danilo De Gregorio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
A Conformation Variant of p53 Combined with Machine Learning Identifies Alzheimer Disease in Preclinical and Prodromal Stages
Giulia Abate et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Investigating the role of 5-HT2A and 5-HT2C receptor activation in the effects of psilocybin, DOI, and citalopram on marble burying in mice
Anna U. Odland et al.
BEHAVIOURAL BRAIN RESEARCH (2021)
Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin ' s main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma
Karolina E. Kolaczynska et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2021)
Connected to the spirit of the frog: An Internet-based survey on Kambo, the secretion of the Amazonian Giant Maki Frog (Phyllomedusa bicolor): Motivations for use, settings and subjective experiences
Tomislav Majic et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2021)
Study Protocol for Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study
Meg J. Spriggs et al.
FRONTIERS IN PSYCHIATRY (2021)
Registered clinical studies investigating psychedelic drugs for psychiatric disorders
Ashley N. Siegel et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2021)
Rediscovering Psilocybin as an Antidepressive Treatment Strategy
Rene Zeiss et al.
PHARMACEUTICALS (2021)
The Therapeutic Potential of Psilocybin
Henry Lowe et al.
MOLECULES (2021)
Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans
Paul Cumming et al.
MOLECULES (2021)
Trial of Psilocybin versus Escitalopram for Depression
Robin Carhart-Harris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
An Encounter With the Other: A Thematic and Content Analysis of DMT Experiences From a Naturalistic Field Study
Pascal Michael et al.
FRONTIERS IN PSYCHOLOGY (2021)
Multi-Target Directed Ligands (MTDLs) Binding the σ1 Receptor as Promising Therapeutics: State of the Art and Perspectives
Francesca Serena Abatematteo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
N,N-Dimethyltryptamine attenuates spreading depolarization and restrains neurodegeneration by sigma-1 receptor activation in the ischemic rat brain
Irisz Szabo et al.
NEUROPHARMACOLOGY (2021)
(2816) Proposal to conserve the name Echinocactus williamsii Lem. ex Salm-Dyck (Lophophora williamsii) against E. williamsianus Lem. (Cactaceae)
Anton Hofer
TAXON (2021)
Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics
Lily R. Aleksandrova et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2021)
Role of the 5-HT2A Receptor in Acute Effects of LSD on Empathy and Circulating Oxytocin
Friederike Holze et al.
FRONTIERS IN PHARMACOLOGY (2021)
Ibogaine Blocks Cue- and Drug-Induced Reinstatement of Conditioned Place Preference to Ethanol in Male Mice
Gabrielle M. Henriques et al.
FRONTIERS IN PHARMACOLOGY (2021)
Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics
Cato M. H. de Vos et al.
FRONTIERS IN PSYCHIATRY (2021)
Variation in Phytochemical, Antioxidant and Volatile Composition of Pomelo Fruit (Citrus grandis (L.) Osbeck) during Seasonal Growth and Development
Arun Kumar Gupta et al.
PLANTS-BASEL (2021)
Investigation of the Structure-Activity Relationships of Psilocybin Analogues
Adam K. Klein et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes
Gabrielle Agin-Liebes et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
Potential identification of an entheogenic plant species on the Chi Silk Manuscript
Benjamin Pothier
TIME & MIND-THE JOURNAL OF ARCHAEOLOGY CONSCIOUSNESS AND CULTURE (2021)
Lysergic acid diethylamide (LSD) promotes social behaviour through 5-HT2A and ampa in the medial prefrontal cortex (MPFC)
A. Markopoulos et al.
EUROPEAN PSYCHIATRY (2021)
Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression
Meghan Hibicke et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Diversity of Claviceps paspali reveals unknown lineages and unique alkaloid genotypes
H. Oberti et al.
MYCOLOGIA (2020)
Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers
Neiloufar Family et al.
PSYCHOPHARMACOLOGY (2020)
A Single Administration of the Atypical Psychedelic Ibogaine or Its Metabolite Noribogaine Induces an Antidepressant-Like Effect in Rats
Paola Rodriguez et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Effects of ayahuasca on mental health and quality of life in naive users: A longitudinal and cross-sectional study combination
Daniel F. Jimenez-Garrido et al.
SCIENTIFIC REPORTS (2020)
Pharmacokinetics and subjective effects of 1P-LSD in humans after oral and intravenous administration
Christina Grumann et al.
DRUG TESTING AND ANALYSIS (2020)
N,N-dimethyltryptamine reduces infarct size and improves functional recovery following transient focal brain ischemia in rats
Sandor Nardai et al.
EXPERIMENTAL NEUROLOGY (2020)
Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models
Claire J. Foldi et al.
FRONTIERS IN NEUROSCIENCE (2020)
Acute Effects of 2C-E in Humans: An Observational Study
Esther Papaseit et al.
FRONTIERS IN PHARMACOLOGY (2020)
Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin
N. L. Mason et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Chemical and structural investigation of the paroxetine-human serotonin transporter complex
Jonathan A. Coleman et al.
ELIFE (2020)
Neuroprotective potential of Ayahuasca and untargeted metabolomics analyses: applicability to Parkinson's disease
Albert Katchborian-Neto et al.
JOURNAL OF ETHNOPHARMACOLOGY (2020)
Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor
Kuglae Kim et al.
CELL (2020)
Molecular basis of β-arrestin coupling to formoterol-bound β1-adrenoceptor
Yang Lee et al.
NATURE (2020)
Plant behaviour: an evolutionary response to the environment?
A. Kumar et al.
PLANT BIOLOGY (2020)
Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study
Nadia R. P. W. Hutten et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Taxonomic Study of the Genus Pholiota (Strophariaceae, Basidiomycota) in Korea
Jun Won Lee et al.
MYCOBIOLOGY (2020)
Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids N,N-Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact
Andreia Machado Brito-da-Costa et al.
PHARMACEUTICALS (2020)
Novel treatment of opioid use disorder using ibogaine and iboga in two adults
Claire Wilson et al.
JOURNAL OF PSYCHEDELIC STUDIES (2020)
Psychedelics as a Treatment for Alzheimer's Disease Dementia
Simon Andrew Vann Jones et al.
FRONTIERS IN SYNAPTIC NEUROSCIENCE (2020)
The Ibogaine Experience: A Qualitative Study on the Acute Subjective Effects of Ibogaine
Maja Kohek et al.
ANTHROPOLOGY OF CONSCIOUSNESS (2020)
Microdosing psychedelics: Motivations, subjective effects and harm reduction
Toby Lea et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2020)
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
Fernanda Palhano-Fontes et al.
PSYCHOLOGICAL MEDICINE (2019)
Differentiating PTSD from anxiety and depression: Lessons from the ICD-11 PTSD diagnostic criteria
Anna C. Barbano et al.
DEPRESSION AND ANXIETY (2019)
Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice
Adam L. Halberstadt et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Cannabimimetic plants: are they new cannabinoidergic modulators?
Amit Kumar et al.
PLANTA (2019)
A systematic study of microdosing psychedelics
Vince Polito et al.
PLOS ONE (2019)
5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety
Alan K. Davis et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2019)
Ibogaine Administration Modifies GDNF and BDNF Expression in Brain Regions Involved in Mesocorticolimbic and Nigral Dopaminergic Circuits
Soledad Marton et al.
FRONTIERS IN PHARMACOLOGY (2019)
Updated View on the Relation of the Pineal Gland to Autism Spectrum Disorders
Tal Shomrat et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport
Jonathan A. Coleman et al.
NATURE (2019)
A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms
M. V. Uthaug et al.
PSYCHOPHARMACOLOGY (2019)
N,N-dimethyltryptamine Prevents Renal Ischemia-Reperfusion Injury in a Rat Model
Balazs Nemes et al.
TRANSPLANTATION PROCEEDINGS (2019)
Conformational dynamics of the human serotonin transporter during substrate and drug binding
Ingvar R. Moller et al.
NATURE COMMUNICATIONS (2019)
Metabolism of lysergic acid diethylamide (LSD): an update
Rui Filipe Libanio Osorio Marta
DRUG METABOLISM REVIEWS (2019)
Neuronal Sigma-1 Receptors: Signaling Functions and Protective Roles in Neurodegenerative Diseases
Daniel A. Ryskamp et al.
FRONTIERS IN NEUROSCIENCE (2019)
Classical psychedelics for the treatment of depression and anxiety: A systematic review
Silvia Muttoni et al.
JOURNAL OF AFFECTIVE DISORDERS (2019)
Inappropriate Intrusion of an Axonal Mitochondrial Anchor into Dendrites Causes Neurodegeneration
Dinesh C. Joshi et al.
CELL REPORTS (2019)
Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions
Ricardo Jorge Dinis-Oliveira et al.
CURRENT MOLECULAR PHARMACOLOGY (2019)
Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents
Lindsay P. Cameron et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Structural insight into the serotonin (5-HT) receptor family by molecular docking, molecular dynamics simulation and systems pharmacology analysis
Yuan-qiang Wang et al.
ACTA PHARMACOLOGICA SINICA (2019)
Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial
Raissa Nobrega de Almeida et al.
FRONTIERS IN PSYCHOLOGY (2019)
LSD modulates effective connectivity and neural adaptation mechanisms in an auditory oddball paradigm
Christopher Timmermann et al.
NEUROPHARMACOLOGY (2018)
Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study
Geoffrey E. Noller et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2018)
Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes
Thomas Kingsley Brown et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2018)
Dark Classics in Chemical Neuroscience: Mescaline
Bruce K. Cassels et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Anatomically distinct representatives of Cactaceae Juss. family have different response to acute heat shock stress
Nataliia Nuzhyna et al.
FLORA (2018)
Psychedelics: Where we are now, why we got here, what we must do
Sean J. Belouin et al.
NEUROPHARMACOLOGY (2018)
Psychedelics Promote Structural and Functional Neural Plasticity
Calvin Ly et al.
CELL REPORTS (2018)
Hypothesis: The Psychedelic Ayahuasca Heals Traumatic Memories via a Sigma 1 Receptor-Mediated Epigenetic-Mnemonic Process
Antonio Inserra
FRONTIERS IN PHARMACOLOGY (2018)
Ibogaine Detoxification Transitions Opioid and Cocaine Abusers Between Dependence and Abstinence: Clinical Observations and Treatment Outcomes
Deborah C. Mash et al.
FRONTIERS IN PHARMACOLOGY (2018)
The Psychedelic Debriefing in Alcohol Dependence Treatment: Illustrating Key Change Phenomena through Qualitative Content Analysis of Clinical Sessions
Elizabeth M. Nielson et al.
FRONTIERS IN PHARMACOLOGY (2018)
Crystal structure of the human 5-HT1B serotonin receptor bound to an inverse agonist
Wanchao Yin et al.
CELL DISCOVERY (2018)
Serum and plasma brain-derived neurotrophic factor and response in a randomized controlled trial of riluzole for treatment resistant depression
Samuel T. Wilkinson et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history
Sara Anna Bonini et al.
JOURNAL OF ETHNOPHARMACOLOGY (2018)
Ergot alkaloid production in Claviceps purpurea is regulated by tryptophan related genes
M. Hradilov et al.
NEW BIOTECHNOLOGY (2018)
N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function
Steven A. Barker
FRONTIERS IN NEUROSCIENCE (2018)
Synesthetic hallucinations induced by psychedelic drugs in a congenitally blind man
Sara Dell'Erba et al.
CONSCIOUSNESS AND COGNITION (2018)
Changes in Withdrawal and Craving Scores in Participants Undergoing Opioid Detoxification Utilizing Ibogaine
Benjamin J. Malcolm et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2018)
Protocols for Subtomogram Averaging of Membrane Proteins in the Dynamo Software Package
Paula P. Navarro et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2018)
Dendrite and Spine Modifications in Autism and Related Neurodevelopmental Disorders in Patients and Animal Models
Veronica Martinez-Cerdeno
DEVELOPMENTAL NEUROBIOLOGY (2017)
Psilocybin for treating substance use disorders?
Bas T. H. de Veen et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
Long-term follow-up of psilocybin-facilitated smoking cessation
Matthew W. Johnson et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2017)
Psilocybin for treating substance use disorders?
Bas T. H. de Veen et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
Disrupted integration of sensory stimuli with information about the movement of the body as a mechanism explaining LSD-induced experience
Grzegorz R. Juszczak
MEDICAL HYPOTHESES (2017)
The Mechanisms of Psychedelic Visionary Experiences: Hypotheses from Evolutionary Psychology
Michael J. Winkelman
FRONTIERS IN NEUROSCIENCE (2017)
Disease modification and Neuroprotection in neurodegenerative disorders
Jeffrey Cummings
TRANSLATIONAL NEURODEGENERATION (2017)
Drug Abuse and Psychosis: New Insights into Drug- induced Psychosis
Suji Ham et al.
EXPERIMENTAL NEUROBIOLOGY (2017)
Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults
Randall T. Brown et al.
CLINICAL PHARMACOKINETICS (2017)
Examination of the Phenomenology of the Ibogaine Treatment Experience: Role of Altered States of Consciousness and Psychedelic Experiences
Annamarie Heink et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2017)
Psychotria viridis: Chemical constituents from leaves and biological properties
Debora B. S. Soares et al.
ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS (2017)
Crystal Structure of an LSD-Bound Human Serotonin Receptor
Daniel Wacker et al.
CELL (2017)
The role of adult neurogenesis in psychiatric and cognitive disorders
Deana M. Apple et al.
BRAIN RESEARCH (2017)
Neuropharmacology of N,N-dimethyltryptamine
Theresa M. Carbonaro et al.
BRAIN RESEARCH BULLETIN (2016)
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression A SPECT Study
Rafael Faria Sanches et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)
X-ray structures and mechanism of the human serotonin transporter
Jonathan A. Coleman et al.
NATURE (2016)
Classic hallucinogens in the treatment of addictions
Michael P. Bogenschutz et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Ibogaine and addiction in the animal model, a systematic review and meta-analysis
M. Belgers et al.
TRANSLATIONAL PSYCHIATRY (2016)
The Endogenous Hallucinogen and Trace Amine N,N-Dimethyltryptamine (DMT) Displays Potent Protective Effects against Hypoxia via Sigma-1 Receptor Activation in Human Primary iPSC-Derived Cortical Neurons and Microglia-Like Immune Cells
Attila Szabo et al.
FRONTIERS IN NEUROSCIENCE (2016)
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
Rafael G. dos Santos et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2016)
Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat
Aline Pic-Taylor et al.
BEHAVIOURAL PROCESSES (2015)
Effect of Psilocin on Extracellular Dopamine and Serotonin Levels in the Mesoaccumbens and Mesocortical Pathway in Awake Rats
Yuichi Sakashita et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2015)
The Anti-Addiction Drug Ibogaine and the Heart: A Delicate Relation
Xaver Koenig et al.
MOLECULES (2015)
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
Flavia de L. Osorio et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2015)
Urine Mescaline Screening With a Biochip Array Immunoassay and Quantification by Gas Chromatography-Mass Spectrometry
Dilek Battal et al.
THERAPEUTIC DRUG MONITORING (2015)
Research on Acute Toxicity and the Behavioral Effects of Methanolic Extract from Psilocybin Mushrooms and Psilocin in Mice
Olga Zhuk et al.
TOXINS (2015)
Ascending-Dose Study of Noribogaine in Healthy Volunteers: Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability
Paul Glue et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2015)
LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects
Peter Gasser et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
The role of 5-HT2A, 5-HT2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice
Theresa M. Carbonaro et al.
PSYCHOPHARMACOLOGY (2015)
Ayahuasca from Peru to Uruguay: Ritual Design and Redesign through a Distributed Cognition Approach
Ismael Apud
ANTHROPOLOGY OF CONSCIOUSNESS (2015)
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
Peter Gasser et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2014)
Psychopharmacological Neuroprotection in Neurodegenerative Disease: Assessing the Preclinical Data
Edward C. Lauterbach et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2014)
Treating drug dependence with the aid of ibogaine: A retrospective study
Eduardo Ekman Schenberg et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
The Consumption of Psychoactive Plants in Ancient Global and Anatolian Cultures During Religious Rituals: The Roots of the Eruption of Mythological Figures and Common Symbols in Religions and Myths
H. Umit Sayin
NeuroQuantology (2014)
Novel pyrazole derivatives as neutral CB1 antagonists with significant activity towards food intake
Ilaria Manca et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity
Ede Frecska et al.
JOURNAL OF NEURAL TRANSMISSION (2013)
Role of the 5-HT2A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice
Adam L. Halberstadt et al.
NEUROPHARMACOLOGY (2013)
Structural Basis for Molecular Recognition at Serotonin Receptors
Chong Wang et al.
SCIENCE (2013)
NESS038C6, a novel selective CB1 antagonist agent with anti-obesity activity and improved molecular profile
Andrea Mastinu et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Metabolic plasticity and the energy economizing effect of ibogaine, the principal alkaloid of Tabernanthe iboga
Roman Paskulin et al.
JOURNAL OF ETHNOPHARMACOLOGY (2012)
Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials
Teri S. Krebs et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
A Prehistoric Mural in Spain Depicting Neurotropic Psilocybe Mushrooms?
Brian P. Akers et al.
ECONOMIC BOTANY (2011)
Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies
Erich Studerus et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment
M. L. Molendijk et al.
MOLECULAR PSYCHIATRY (2011)
Partial Agonists of the α3β4*Neuronal Nicotinic Acetylcholine Receptor Reduce Ethanol Consumption and Seeking in Rats
Susmita Chatterjee et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists
Jose L. Moreno et al.
NEUROSCIENCE LETTERS (2011)
Non-Competitive Inhibition by Active Site Binders
Yuval Blat
CHEMICAL BIOLOGY & DRUG DESIGN (2010)
Sacred plants and visionary consciousness
Jose Luis Diaz
PHENOMENOLOGY AND THE COGNITIVE SCIENCES (2010)
Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter
Nicholas V. Cozzi et al.
JOURNAL OF NEURAL TRANSMISSION (2009)
The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator
Dominique Fontanilla et al.
SCIENCE (2009)
When the Endogenous Hallucinogenic Trace Amine N,N-Dimethyltryptamine Meets the Sigma-1 Receptor
Tsung-Ping Su et al.
SCIENCE SIGNALING (2009)
LSD-assisted psychotherapy in persons suffering from anxiety associated with advanced-stage life threatening diseases. A phase-II, double-blind, placebo-controlled dose-response pilot study
Torsten Passie et al.
CNS NEUROSCIENCE & THERAPEUTICS (2008)
Hallucinogenic Mushrooms in Mexico: An Overview
Gaston Guzman
ECONOMIC BOTANY (2008)
Ibogaine, a noncompetitive inhibitor of serotonin transport, acts by stabilizing the cytoplasm-facing state of the transporter
Miriam T. Jacobs et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior
Javier Gonzalez-Maeso et al.
NEURON (2007)
The creativity of Crumb: Research on the effects of psychedelic drugs on the comic art of Robert Crumb
Matthew T. Jones
JOURNAL OF PSYCHOACTIVE DRUGS (2007)
C-(4,5,6-trimethoxyindan-1-yl)methanamine:: A mescaline analogue designed using a homology model of the 5-HT2A receptor
Thomas H. McLean et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): A double-blind, cross-over study in healthy volunteers
E Gouzoulis-Mayfrank et al.
PHARMACOPSYCHIATRY (2005)
The 5-HT1A receptor and the stimulus effects of LSD in the rat
CJ Reissig et al.
PSYCHOPHARMACOLOGY (2005)
Nicotinic agonists, antagonists, and modulators from natural sources
JW Daly
CELLULAR AND MOLECULAR NEUROBIOLOGY (2005)
Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors
L Lindemann et al.
GENOMICS (2005)
Glial cell line-derived neurotrophic factor mediates the desirable actions of the anti-addiction drug ibogaine against alcohol consumption
DY He et al.
JOURNAL OF NEUROSCIENCE (2005)
Characterization of an allosteric citalopram-binding site at the serotonin transporter
FH Chen et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Novel iboga alkaloid congeners block nicotinic receptors and reduce drug self-administration
CJ Pace et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Announcing the worldwide Protein Data Bank
H Berman et al.
NATURE STRUCTURAL BIOLOGY (2003)
Lbogaine attenuation of morphine withdrawal in mice:: role of glutamate N-methyl-D-aspartate receptors
MB Leal et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2003)
Plasma membrane monoamine transporters: Structure, regulation and function
GE Torres et al.
NATURE REVIEWS NEUROSCIENCE (2003)
One hundred and seventeen clades of euagarics
JM Moncalvo et al.
MOLECULAR PHYLOGENETICS AND EVOLUTION (2002)
Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration
SD Glick et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Iboga compounds reverse the behavioural disinhibiting and corticosterone effects of acute methamphetamine:: Implications for their antiaddictive properties
KK Szumlinski et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2001)